HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
about
Artemisinin-based combination therapy for uncomplicated P. falciparum malaria in children with HIVArtemisinin-based combination therapy for uncomplicatedP. falciparummalaria in children with HIVAntigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malariaImmunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities.Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area.Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria.The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells.Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolatesImmunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes.Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes.Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction.Advances and challenges in malaria vaccine development.Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytesHigh avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria.Designing a VAR2CSA-based vaccine to prevent placental malaria.Association between immunoglobulin GM and KM genotypes and placental malaria in HIV-1 negative and positive women in western KenyaInduction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy.Malaria and immunity during pregnancy and postpartum: a tale of two speciesProspects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA.Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya.Malaria during Pregnancy.Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.Complement Activation in Placental Malaria.Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.A model of parity-dependent immunity to placental malaria.Evidence for spleen dysfunction in malaria-HIV co-infection in a subset of pediatric patients.HIV and co-infections.Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malariaSkin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunityThe Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study.A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy.Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.Assessing the burden of pregnancy-associated malaria under changing transmission settings.
P2860
Q24235145-5F13E043-FA11-4B63-876F-6B1B21AF9413Q26471338-DB1869F4-CCE7-461B-A896-0346E96EDDE8Q30603697-5504309E-7A64-4F14-A42D-0AD1E78A4846Q33346254-17188BCD-E627-4925-A83C-F8F874E9ADF4Q33532592-E0E75932-E9FC-4973-9259-86E6973A1228Q33593182-95BC5BE2-A1B2-4773-8A79-CF698913C283Q33634432-5D14AEB1-E96A-4E67-93F1-ADEC5A7F9696Q33822296-BD95E244-D5A8-4424-A20C-B446ADAED8D3Q33826076-542D915A-863F-449B-9189-A4458D0D5DAAQ33980021-0B614F90-7007-4814-981F-9E286FB191C9Q34037890-CCD31521-C49E-49CC-AB44-8B0C5891E3F0Q34145333-E77C043C-A620-477F-8AF2-53556BA1CDDDQ34161839-9ECFEFDD-38BB-440A-801B-9FD3452DC77CQ34171651-6A3C6713-4456-44A8-BD07-3F47E71EDC7FQ34326742-BD5BC969-20BF-4AF7-8F8B-212BB7624134Q34498103-7D2D4457-9D45-4B8D-9B64-D51DB68A1347Q34551986-F09A6313-BC9B-4D4F-B8AE-A68869F7D953Q34660001-556FA957-CA57-44A6-B2DF-00DF73D3747FQ34740303-D1BD7354-90FF-4981-A8BC-8B441B123F03Q35678578-F65D65C7-450E-4889-948A-94F93D71A206Q35738477-78744AB4-2AFC-4302-A576-7CB4718B93C2Q35783076-5A333B6C-ADFD-48CD-89C8-CFD6EC5CEF8EQ35830624-D3086A73-1627-46C5-A434-8E48A84BBA3FQ36284603-82DDE104-5902-4818-9F02-1C2766043CD8Q36336978-AFD05D21-F554-4B1A-AD27-C1CB73940AF8Q36387332-19D09939-7460-4EEB-B7AA-6E82520EE59DQ36539548-26E60DB1-75D5-46E1-9054-D96B5A6B1281Q36672347-E107A358-79C3-4839-8782-4C8DB37BAFDCQ36691835-7EE2A7EB-FE6A-4277-BE43-0403CE1E0638Q36705870-7ABFDADA-288C-4D16-8061-A3C8EABD2F78Q36737343-9BEEBD39-8E14-4503-85CA-421C1F555553Q36739485-F6F8D2A4-1F8C-4497-8AEB-D2C42576DF6BQ36970184-F6AD8695-A59A-4226-8463-0E93DB6A41FFQ37116542-C6A0BC3A-1C7E-425B-B5A6-55449AA24142Q37254129-93CCC921-7940-4995-9F0E-F489C10FBF25Q37297061-534EC5EC-D161-4C9B-90FA-D304F87BB828Q37298050-3EAEE0CF-2E05-4681-A50A-B36B6910CB2CQ37382365-2267E696-40DC-4F69-B319-9559CBB736CDQ37406034-97853576-BFEF-41EE-9C88-F0B25B992458Q37414302-546A1AC7-E5AB-4BAB-AA77-6E3D14CD1FA8
P2860
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
@ast
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
@en
type
label
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
@ast
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
@en
prefLabel
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
@ast
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
@en
P2093
P2860
P50
P1433
P1476
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
@en
P2093
Anne van Eijk
Jessica Keen
John Ayisi
Samir N Patel
P2860
P356
10.1371/JOURNAL.PMED.0040181
P407
P577
2007-05-01T00:00:00Z